Cargando…
Screening Method for Anti-Colon Cancer Drugs Using Two Sensor Cell Lines with Human β4-Galactosyltransferase 4 Gene Promoters
The increased expression of β4-galactosyltransferase (β4GalT) 4 is closely associated with poor prognosis of colon cancer. Recently, we showed that the expression of the β4GalT4 gene is regulated by the 0.17 kb core promoter region containing one binding site for Specificity protein 1 (Sp1). To deve...
Autores principales: | Fukushima, Naomichi, Sugiyama, Atena, Sato, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111286/ https://www.ncbi.nlm.nih.gov/pubmed/30082623 http://dx.doi.org/10.3390/s18082573 |
Ejemplares similares
-
Challenge to the suppression of tumor growth by the β4-galactosyltransferase genes
por: FURUKAWA, Kiyoshi
Publicado: (2015) -
The Impact of β-1,4-Galactosyltransferase V on Microglial Function
por: Wang, Xiaoyu, et al.
Publicado: (2021) -
An acceptor analogue of β-1,4-galactosyltransferase: Substrate, inhibitor, or both?
por: Jiang, Jingqian, et al.
Publicado: (2017) -
N-glycosylation of the human β1,4-galactosyltransferase 4 is crucial for its activity and Golgi localization
por: Shauchuk, Auhen, et al.
Publicado: (2020) -
Glycosphingolipid-associated β-1,4 galactosyltransferase is elevated in patients with systemic lupus erythematosus
por: Sadras, Vignesh, et al.
Publicado: (2020)